Correction: Chavda et al. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review.
Molecules (Basel, Switzerland)
January 1, 1970
Vivek P Chavda et al. (5 authors)
Published ErratumHuman StudyAnimal Study
Extracted Claims (3)
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
vitamin D supplementation | decrease | fracture risk | elderly adults | 35% | significantly reduced | #1 |
Omega-3 fatty acids | no change | cardiovascular events | patients with type 2 diabetes | no significant change | showed no effect | #2 |
Creatine supplementation | increase | muscle strength | Wistar rats | 15% | increased | #3 |
Abstract
There was an error in the original paper [...].
Study Links
PubMed ID40142172
Related Supplements